A 65-year-old client on chronic warfarin for atrial fibrilla… | MyMerci
Medical EmergenciesPA
Question
A 65-year-old client on chronic warfarin for atrial fibrillation has just completed an elective abdominal hernia repair. Pre-operatively warfarin was held 5 days and the client was bridged with therapeutic enoxaparin, with the last dose given 24 hours pre-op. The surgical team confirms hemostasis and no active bleeding. Per a typical bridge protocol, when does the nurse anticipate the orders to resume the bridge anticoagulation?
1Hold all anticoagulation for 7 days post-op to allow complete healing.
2Resume warfarin only and skip enoxaparin since the surgery is complete.
3Resume therapeutic-dose enoxaparin and oral warfarin within 1 hour of arrival on the surgical floor.
4Resume therapeutic-dose enoxaparin approximately 24-72 hours post-operatively (depending on bleeding risk) once hemostasis is confirmed, typically restart oral warfarin the same day or next day, and continue overlap until INR is therapeutic.✓ Correct answer
Explanation
Post-operative resumption of bridge anticoagulation Resumption timing balances the risk of bleeding from the surgical site against the risk of thromboembolic events (stroke, DVT/PE). Standard approach (per CHEST and ACC guidelines):
• Hemostasis confirmed by surgical team is the first prerequisite. • Low bleeding risk procedures: resume therapeutic LMWH ~24 hours post-op. • High bleeding risk procedures (major abdominal, neuraxial, intracranial, vascular): wait 48-72 hours; consider prophylactic-dose LMWH first, then advance to therapeutic dose. • Warfarin restart: typically the day of surgery or the next day (because warfarin takes 5-7 days to achieve therapeutic INR). • Overlap LMWH and warfarin until INR is therapeutic (≥2.0) for 24-48 hours, then discontinue LMWH. • Continue prophylactic VTE measures (mechanical compression, ambulation, hydration) until therapeutic anticoagulation resumes. • Adjust based on individual bleeding/clotting risk; monitor for hematoma, bleeding, thrombosis.
Option 3 (1 hour) is too soon for therapeutic anticoagulation. Option 1 (7 days) is too long and increases thromboembolic risk. Option 2 (warfarin only) ignores the protective bridge needed during warfarin warm-up.
In-depth explanation
Clinical reasoning summary Post-operative resumption of bridge anticoagulation Resumption timing balances the risk of bleeding from the surgical site against the risk of thromboembolic events (stroke, DVT/PE). Standard approach (per CHEST and ACC guidelines):
• Hemostasis confirmed by surgical team is the first prerequisite. • Low bleeding risk procedures: resume therapeutic LMWH ~24 hours post-op. • High bleeding risk procedures (major abdominal, neuraxial, intracranial, vascular): wait 48-72 hours; consider prophylactic-dose LMWH first, then advance to therapeutic dose. • Warfarin restart: typically the day of surgery or the next day (because warfarin takes 5-7 days to achieve therapeutic INR). • Overlap LMWH and warfarin until INR is therapeutic (≥2.0) for 24-48 hours, then discontinue LMWH. • Continue prophylactic VTE measures (mechanical compression, ambulation, hydration) until therapeutic anticoagulation resumes. • Adjust based on individual bleeding/clotting risk; monitor for hematoma, bleeding, thrombosis.
Option 1 (1 hour) is too soon for therapeutic anticoagulation. Option 3 (7 days) is too long and increases thromboembolic risk. Option 4 (warfarin only) ignores the protective bridge needed during warfarin warm-up.